| Literature DB >> 16489258 |
Agnieszka Zebrowska1, Joanna Narbutt, Anna Sysa-Jedrzejowska, Jozef Kobos, Elzbieta Waszczykowska.
Abstract
Dermatitis herpetiformis (DH) is a subepidermal autoimmune disease characterized by skin and intestinal lesions consistent with coeliac disease. There are also some data that metalloproteinases (MMPs) are involved in the development of skin lesions in DH, however their exact role in this process is not fully understood. The aim of the study was to investigate whether MMPs and their inhibitors are involved in pathogenesis of DH. Skin biopsies were taken from 13 patients with active DH and from 10 healthy subjects. The localization and expression of MMPs and TIMPs were examined by immunohistochemistry. MMPs expression was detected in basal keratinocytes and in the whole epidermis in all of the DH subjects. Neutrophils in microabscesses and in blister fluid were also positive for MMPs. Expression of TIMPs was moderate or weak in all examined biopsies. Our results allow us to conclude that imbalance between these enzymes takes an important role in the pathogenesis of DH.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16489258 PMCID: PMC1533900 DOI: 10.1155/MI.2005.373
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Expression of MMPs and TIMPs in examined tissues. ND: nondetectable.
| Localization | |||||||
| Positive biopsies/all biopsies | |||||||
| Enzyme | Basal | Whole | Microabscesses | Infiltration | Stromal | Hair | Blister |
| keratinocytes | epidermis | cells | follicle | fluid | |||
| Patients | ( | ( | |||||
| MMP1 | 13/13 | 13/13 | 4/13 | 13/13 | 5/13 | ND | 5/7 |
| MMP2 | 13/13 | 13/13 | 4/13 | 1/13 | 3/13 | ND | 5/7 |
| MMP9 | 13/13 | 9/13 | 7/13 | 2/13 | 3/13 | ND | 6/7 |
| MMP10 | 13/13 | 12/13 | 7/13 | 9/13 | 2/13 | ND | 5/7 |
| TIMP1 | 13/13 | 13/13 | 9/13 | 5/13 | 2/13 | ND | 7/7 |
| TIMP2 | 13/13 | 13/13 | 7/13 | 4/13 | 3/13 | ND | 4/7 |
| TIMP3 | 13/13 | 13/13 | 6/13 | 4/13 | 3/13 | ND | 3/7 |
| Controls | ( | ||||||
| MMP1 | Single | — | — | — | — | 4/10 | — |
| keratinocytes | |||||||
| MMP2 | Single | — | — | — | — | 4/10 | — |
| keratinocytes | |||||||
| MMP9 | Single | — | — | — | — | 4/10 | — |
| keratinocytes | |||||||
| MMP10 | Single | — | — | — | — | 4/10 | — |
| keratinocytes | |||||||
| TIMP1 | Single | — | — | — | — | 4/10 | — |
| keratinocytes | |||||||
| TIMP2 | Single | — | — | — | — | 4/10 | — |
| keratinocytes | |||||||
| TIMP3 | Single | — | — | — | — | 4/10 | — |
| keratinocytes | |||||||
Figure 1Skin lesions. Immunohistochemistry. Moderate expression of MMP1 in the whole epidermis and in blister fluid (magnification: × 100).
Figure 2Skin lesions. Immunohistochemistry. High expression of MMP10 in the whole epidermis and in blister fluid (magnification: × 100).
Figure 3Skin lesions. Immunohistochemistry. Weak expression of TIMP1 in the whole epidermis (magnification: × 100).
Figure 4Healthy skin. Immunohistochemistry. Expression of MMP1 in single basal keratinocyte. Biopsy from healthy individual (magnification: × 400).
Figure 5Healthy skin. Immunohistochemistry. Expression of TIMP1 in single keratinocyte (magnification: × 400).